Zolendronate-associated inflammatory orbital disease

New Zealand Medical Journal

Volumn 123, Issue 1323, 2010, Pages 50-52

  Yeo, Jennifer ^a   Jafer, Ali ^a  

^a NORTH SHORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN; ZOLEDRONIC ACID;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CAVERNOUS SINUS THROMBOSIS; HUMAN; INFLAMMATORY ORBITAL DISEASE; MALE; NEUROPATHIC JOINT DISEASE; NEUTROPHIL COUNT; ORBIT DISEASE; PERIORBITAL EDEMA;

BONE DENSITY CONSERVATION AGENTS; DIABETIC FOOT; DIAGNOSIS, DIFFERENTIAL; DIPHOSPHONATES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; ORBITAL DISEASES;

EID: 77958039274     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Medsafe. 2009. Data Sheet for Zolendronate. http://www.medsafe.govt.nz
2. Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology. 2001;40:956-957. (Pubitemid 32816080)
3. Phillips PM, Newamn SA. Orbital inflammatory disease after intravenous infusion of zolendronate for treatment of metastatic renal cell carcinoma. Arch Ophthalmol 2008;126(1):137-139.
4. Sharma N, Ooi J, Masselos K, et al. Zolendronic acid infusion and orbital inflammatory disease. N Engl Journal of Med. 2008;359;13:1410-1411.
5. Subramanian P, Kerrison J, Calvert P, Miller N. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalomol. 2003;121:1335-1336. (Pubitemid 37128418)
6. Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl Journal of Med 1999;340;9:737-738.